Researchers find that living with chronic pain is associated with a significantly higher risk of developing dementia.

A major study reveals unexpected and nuanced findings about the relationship between alcohol consumption and dementia.

Despite approval, the new Alzheimer's drug Leqembi is likely to be financially out of reach for most patients.

The Alzheimer's drug lecanemab receives accelerated FDA approval despite ongoing safety discussions.